metformin has been researched along with Neoplasms, Pleural in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to investigate the effect of metformin on survival of people with type 2 diabetes and pleural mesothelioma." | 7.83 | Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study. ( Brewster, DH; Damhuis, RA; Walker, J; Wild, SH; Wu, H, 2016) |
| "This study aimed to investigate the effect of metformin on survival of people with type 2 diabetes and pleural mesothelioma." | 3.83 | Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study. ( Brewster, DH; Damhuis, RA; Walker, J; Wild, SH; Wu, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, H | 1 |
| Walker, J | 1 |
| Damhuis, RA | 1 |
| Brewster, DH | 1 |
| Wild, SH | 1 |
1 other study available for metformin and Neoplasms, Pleural
| Article | Year |
|---|---|
Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study.
Topics: Aged; Aged, 80 and over; Cause of Death; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; | 2016 |